AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy

AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy

Abstract Background Immediate hypersensitivity reactions to COVID-19 vaccines have been postulated to be linked to their excipients, such as polyethylene glycol (PEG) in Pfizer Comirnaty, or polysorbate 80 and ethylenediaminetetracetic acid (EDTA) in AstraZeneca ChAdOx1-S [recombinant] (Vaxzevria)....

Full description

Bibliographic Details
Main Authors: Syed B. Ali, Griffith Perkins, Dongjae Ryoo, Maverick Lee, Matthew Tunbridge, Chino Yuson, William Smith, Pravin Hissaria, Thanh-Thao Le
Format: Article
Language:English
Published: BMC 2022-03-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
COVID-19
Vaccine allergy
EDTA
Excipients
Online Access:https://doi.org/10.1186/s13223-022-00665-3

Internet

https://doi.org/10.1186/s13223-022-00665-3

Similar Items